Cargando…

Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS

This monocentric prospective study of patient suffering from Amyotrophic lateral sclerosis (ALS) aims to evaluate the prognosis and diagnostic potential of both Neurofilament-Light (Nf-L) and neuroinflammatory biomarkers in serum and CSF. Candidate markers levels were measured using multiplex method...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brodovitch, Alexandre, Boucraut, José, Delmont, Emilien, Parlanti, Amandine, Grapperon, Aude-Marie, Attarian, Shahram, Verschueren, Annie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803734/ https://www.ncbi.nlm.nih.gov/pubmed/33436881 http://dx.doi.org/10.1038/s41598-020-80370-6

Ejemplares similares

Structural Connectivity Alterations in Amyotrophic Lateral Sclerosis: A Graph Theory Based Imaging Study
por: Fortanier, Etienne, et al.
Publicado: (2019)

Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen‐specific glycopolymer
por: Aliu, Butrint, et al.
Publicado: (2020)

CSF neurofilament light chain reflects corticospinal tract degeneration in ALS
por: Menke, Ricarda A L, et al.
Publicado: (2015)

CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression
por: Sun, Qionghua, et al.
Publicado: (2020)

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
por: Rajabally, Yusuf A, et al.
Publicado: (2020)

Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus
por: Margraf, Nils G., et al.
Publicado: (2023)

Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension
por: Engel, Sinah, et al.
Publicado: (2023)

Is CSF neurofilament light chain measurement relevant for MS?
por: Matsui, Makoto
Publicado: (2020)

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
por: Bergman, Joakim, et al.
Publicado: (2016)

CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls
por: Oosterveld, Linda P., et al.
Publicado: (2019)

The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias
por: Abu-Rumeileh, Samir, et al.
Publicado: (2018)

Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation
por: Bacquet, Juliette, et al.
Publicado: (2018)

Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures
por: Mielke, Michelle M., et al.
Publicado: (2019)

CSF Neurofilament Light Chain Concentrations Predict Outcome in Bacterial Meningitis
por: Chekrouni, Nora, et al.
Publicado: (2021)

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2015)

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders
por: Herbert, Megan K., et al.
Publicado: (2015)

CSF Neurofilament light chain level predicts axonal damage in cerebral vasculitis
por: Pawlitzki, Marc, et al.
Publicado: (2019)

CSF neurofilament light chain testing as an aid to determine treatment strategies in MS
por: Reyes, Saúl, et al.
Publicado: (2020)

Association of CSF and Serum Neurofilament Light and Glial Fibrillary Acidic Protein, Injury Severity, and Outcome in Spinal Cord Injury
por: Stukas, Sophie, et al.
Publicado: (2023)

CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers
por: Rostgaard, Nina, et al.
Publicado: (2018)

CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration
por: Pawlitzki, Marc, et al.
Publicado: (2018)

Chitinase 3–like 1 and neurofilament light chain in CSF and CNS atrophy in MS
por: Schneider, Ruth, et al.
Publicado: (2020)

The repertoire of CSF antiviral antibodies in patients with neuroinflammatory diseases
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2023)

CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome—Sign of Inflammation
por: Pawlitzki, Marc, et al.
Publicado: (2018)

Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis?
por: Kalatha, Thaleia, et al.
Publicado: (2019)

CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis
por: Bhan, Alok, et al.
Publicado: (2021)

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
por: Sjölin, Karl, et al.
Publicado: (2022)

Comparing Neurofilament Light Chain Levels in Serum and Plasma
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing
por: Roggenbuck, Dirk, et al.
Publicado: (2020)

Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model
por: Yeo, Tianrong, et al.
Publicado: (2022)

Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients
por: Sejbaek, Tobias, et al.
Publicado: (2019)

Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study
por: Vacchiano, Veria, et al.
Publicado: (2021)

Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis
por: Alagaratnam, Jasmini, et al.
Publicado: (2021)

CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study
por: Nissen, Mette Scheller, et al.
Publicado: (2021)

Serum neurofilament light chain is increased in hereditary spastic paraplegias
por: Wilke, Carlo, et al.
Publicado: (2018)

Serum Neurofilament light correlates with CADASIL disease severity and survival
por: Gravesteijn, Gido, et al.
Publicado: (2018)

Serum neurofilament light as a biomarker in progressive multiple sclerosis
por: Kapoor, Raju, et al.
Publicado: (2020)

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
por: Hayashi, Tomohiro, et al.
Publicado: (2021)

Enhancing the clinical value of serum neurofilament light chain measurement
por: Kosa, Peter, et al.
Publicado: (2022)

Increased levels of neurofilament light chain in suicide attempters’ serum
por: Ramezani, Mahtab, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b2h6i47pbdk7cqupjml7u5ma9n